O46.013
Antepartum hemorrhage with afibrinogenemia, third trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Antepartum hemorrhage refers to bleeding that occurs during pregnancy, specifically before the delivery of the baby. When bleeding happens in the third trimester, it can pose serious health risks to both mother and baby. One rare but significant cause of this bleeding is afibrinogenemia, a disorder characterized by the absence or extremely low levels of fibrinogen, a protein essential for blood clot formation. The combination of antepartum hemorrhage and afibrinogenemia requires careful medical management to ensure safety during pregnancy and delivery.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to inherited afibrinogenemia, affecting the body's ability to produce fibrinogen. Acquired conditions such as liver disease, which can impair fibrinogen production. Disseminated intravascular coagulation (DIC), a serious condition causing abnormal blood clotting and bleeding. Certain obstetric complications or trauma during pregnancy that can precipitate bleeding episodes.
Key Symptoms: Vaginal bleeding during the third trimester, which may vary in amount. Signs of excessive bleeding, such as blood clots or persistent bleeding after minor injuries or procedures. Possible signs of anemia, including weakness, fatigue, or dizziness due to significant blood loss. Potential signs of complications like abdominal pain or uterine tenderness, indicating more severe issues.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. These may include:
Treatment Protocols: Managing antepartum hemorrhage with afibrinogenemia involves a multidisciplinary approach aimed at controlling bleeding, maintaining maternal health, and ensuring fetal safety. Typical strategies include:
Clinical Advice & FAQs
Billing Guidance
Is O46.013 a billable ICD-10 code?
Yes, O46.013 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O46.013?
Clinical documentation must specify the nature of Antepartum hemorrhage with afibrinogenemia, third trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference